Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and p53

Details for Australian Patent Application No. 2007228784 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Poncelet, Alain Philippe; Joubert, Muriel; Van Hijfte, Luc; Lacrampe, Jean Fernand Armand; Giethlen, Bruno; Schoentjes, Bruno; Meyer, Christophe; Contreras, Jean-Marie; Wermuth, Camille Georges

Agent Shelston IP

Pub. Number AU-B-2007228784

PCT Pub. Number WO2007/107545

Priority 60/785,120 23.03.06 US; 06111529.1 22.03.06 EP

Filing date 19 March 2007

Wipo publication date 27 September 2007

Acceptance publication date 8 March 2012

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/107545 Priority application(s): WO2007/107545

8 March 2012 Application Accepted

  Published as AU-B-2007228784

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007228815-Process for preparing a rubber composition, rubber composition obtained therefrom, and use thereof

2007228782-Inhibitors of the interaction between MDM2 and p53